New advances in radiation biology

Occupational Medicine
Kevin M Prise

Abstract

Current understanding of risk associated with low-dose radiation exposure has for many years been embedded in the linear-no-threshold (LNT) approach, based on simple extrapolation from the Japanese atomic bomb survivors. Radiation biology research has supported the LNT approach although much of this has been limited to relatively high-dose studies. Recently, with new advances for studying effects of low-dose exposure in experimental models and advances in molecular and cellular biology, a range of new effects of biological responses to radiation has been observed. These include genomic instability, adaptive responses and bystander effects. Most have one feature in common in that they are observed at low doses and suggest significant non-linear responses. These new observations pose a significant challenge to our understanding of low-dose exposure and require further study to elucidate mechanisms and determine their relevance.

References

Jan 1, 1969·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·L H Thompson, H D Suit
May 1, 1970·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·K R Trott, O Hug
May 1, 1997·International Journal of Radiation Biology·G E WatsonE G Wright
Feb 11, 1998·International Journal of Radiation Oncology, Biology, Physics·M A KhanJ Van Dyk
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·S A LorimoreE G Wright
Jan 9, 1999·International Journal of Radiation Biology·K M PriseB D Michael
May 13, 1999·Journal of Radiological Protection : Official Journal of the Society for Radiological Protection·C R MuirheadG L Berridge
Aug 16, 2001·Critical Reviews in Toxicology·A C Upton
Jan 18, 2003·Advances in Space Research : the Official Journal of the Committee on Space Research (COSPAR)·K M PriseB D Michael
Aug 30, 2003·Oncogene·Sally A AmundsonAlbert J Fornace
May 1, 1956·The Journal of Experimental Medicine·T T PUCK, P I MARCUS
Oct 15, 2003·Oncogene·Munira A Kadhim
Oct 15, 2003·Oncogene·Yuri E Dubrova
Nov 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·David J BrennerMarco Zaider
Jun 15, 2004·Health Physics·R Julian Preston
Sep 4, 2004·Proceedings of the National Academy of Sciences of the United States of America·Chunlin ShaoKevin M Prise
Jan 27, 2005·Proteomics·Mamoun AhramDavid L Springer
Jun 1, 2005·Cancer Treatment Reviews·Joseph M KaminskiJeffrey Brousal

❮ Previous
Next ❯

Citations

Aug 24, 2012·Journal of Radiation Research·Reem YunisDavid M Rocke
Jan 29, 2009·Radiation Protection Dosimetry·S IncertiPh Moretto
May 11, 2011·PloS One·Emiliano FratiniRoberto Amendola
Jun 26, 2014·PloS One·Anders Pape MøllerGeir Rudolfsen
Dec 25, 2012·Mutation Research·Munira KadhimMark P Little
Apr 13, 2007·Journal of Environmental Radioactivity·C MothersillC B Seymour
Mar 24, 2007·Experimental Hematology·Ludwig E FeinendegenRonald D Neumann
Apr 24, 2013·International Journal of Radiation Biology·Dino NieriAntonio Antoccia
May 11, 2016·Journal of X-ray Science and Technology·Hao GongGuohua Cao
Feb 1, 2018·Dose-response : a Publication of International Hormesis Society·Richard SmithCarmel Mothersill
Mar 24, 2018·International Journal of Radiation Biology·Scott Bright, Munira Kadhim
Dec 15, 2010·Journal of Radiological Protection : Official Journal of the Society for Radiological Protection·Harold T Peterson
Feb 26, 2016·Journal of Radiological Protection : Official Journal of the Society for Radiological Protection·Julie J BurttRobert M Lafrenie
Jul 1, 2016·Science Translational Medicine·Yosi ShamayDaniel A Heller
Oct 13, 2018·BioResearch Open Access·Kamonwan JenwitheesukPhasuk Limrattanapimpa
Jan 12, 2008·Journal of Radiation Research·Munetoshi MaedaKatsumi Kobayashi
Jan 1, 2014·Frontiers in Molecular Biosciences·Rajamanickam BaskarKheng-Wei Yeoh
Jun 20, 2019·Scientific Reports·Maciej RomanWojciech M Kwiatek
Jul 12, 2011·Acta Radiologica·Ernest K J Pauwels, Michel Bourguignon
Oct 11, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Veerle KersemansSean C Smart
Dec 6, 2006·Environmental Science & Technology·C MothersillC B Seymour
Jun 21, 2020·Anti-cancer Agents in Medicinal Chemistry·Chiara Martinelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.